Literature DB >> 6576620

Diabetes--the cost of illness and the cost of control. An estimate for Sweden 1978.

B Jönsson.   

Abstract

This study estimates the economic cost of diabetes mellitus in Sweden 1978. It also addresses the question of potential savings from improved metabolic control. Economic costs of illness include direct costs for medical care and indirect costs from lost production due to morbidity and premature death. The total costs of diabetes are estimated at 1300 million SEK in Sweden 1978. The direct costs for medical care accounted for 43% of these costs. Lost production due to permanent disability is the dominating indirect costs, and accounts for 60% of indirect costs and one third of the total costs. Institutional care accounts for two thirds of the direct costs. The costs for drugs and medical devices amount to 128 million SEK or 1000 SEK per insulin- or oraldependent diabetic. Costs for control of diabetes are estimated to 20% of the total cost and 50% of direct costs. The conclusion is that there are great potential benefits to be expected from improved self control of diabetes.

Entities:  

Mesh:

Year:  1983        PMID: 6576620     DOI: 10.1111/j.0954-6820.1983.tb08543.x

Source DB:  PubMed          Journal:  Acta Med Scand Suppl        ISSN: 0365-463X


  17 in total

1.  Costs of diabetes. A methodological analysis of the literature.

Authors:  E Pagano; M Brunetti; F Tediosi; L Garattini
Journal:  Pharmacoeconomics       Date:  1999-06       Impact factor: 4.981

Review 2.  Cost-effective management of diabetic foot ulcers. A review.

Authors:  G Ragnarson-Tennvall; J Apelqvist
Journal:  Pharmacoeconomics       Date:  1997-07       Impact factor: 4.981

Review 3.  Global healthcare financing for type II diabetes: are there ways out of the crisis?

Authors:  T D Szucs
Journal:  Pharmacoeconomics       Date:  1995       Impact factor: 4.981

Review 4.  Applying recent findings to clinical care in type II diabetes.

Authors:  R Williams
Journal:  Pharmacoeconomics       Date:  1995       Impact factor: 4.981

Review 5.  Costs of insulin-dependent diabetes mellitus.

Authors:  T T Simell; H Sintonen; J Hahl; O G Simell
Journal:  Pharmacoeconomics       Date:  1996-01       Impact factor: 4.981

Review 6.  Direct and indirect costs of cardiovascular and cerebrovascular complications of type II diabetes.

Authors:  K M MacLeod; J E Tooke
Journal:  Pharmacoeconomics       Date:  1995       Impact factor: 4.981

Review 7.  Economic evaluations of type II diabetes.

Authors:  B Leese
Journal:  Pharmacoeconomics       Date:  1995       Impact factor: 4.981

8.  Patient education as the basis for diabetes care in clinical practice and research.

Authors:  J P Assal; I Mühlhauser; A Pernet; R Gfeller; V Jörgens; M Berger
Journal:  Diabetologia       Date:  1985-08       Impact factor: 10.122

9.  Revealing the cost of Type II diabetes in Europe.

Authors:  B Jönsson
Journal:  Diabetologia       Date:  2002-07       Impact factor: 10.122

10.  [Direct cost of the ambulatory management of diabetes at the outpatient clinic of the National Social Security Fund of Sfax (Tunisia)].

Authors:  M Rekik; M Abid; J Hachicha; R Abbes; M Moujahed; A Jarraya
Journal:  Bull World Health Organ       Date:  1994       Impact factor: 9.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.